Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare

by Hyun J. Kim, Amado J. Zurita, Maria E. Suarez-Almazor
Published 2019-03-01

8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition.

by Alper Y Kearney, You-Hong Fan, Uma Giri, Babita Saigal, Varsha Gandhi, John V Heymach, Amado J Zurita
Published 2015-01-01

Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing

by Naveen Ramesh, Emi Sei, Pei Ching Tsai, Shanshan Bai, Yuehui Zhao, Patricia Troncoso, Paul G. Corn, Christopher Logothetis, Amado J. Zurita, Nicholas E. Navin
Published 2020-07-01

A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11.

by Marina Cardó-Vila, Amado J Zurita, Ricardo J Giordano, Jessica Sun, Roberto Rangel, Liliana Guzman-Rojas, Cristiane D Anobom, Ana P Valente, Fábio C L Almeida, Johanna Lahdenranta, Mikhail G Kolonin, Wadih Arap, Renata Pasqualini
Published 2008-01-01

Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events

by Jennifer Wang, Jianjun Gao, Pavlos Msaouel, Padmanee Sharma, Nizar Tannir, Sumit K Subudhi, Eric Jonasch, Amishi Shah, Matthew T Campbell, Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, Tharakeswara K Bathala, Devaki Shilpa Surasi, Sangeeta Goswami, Amado J Zurita, Paul G Corn, Ana M Aparicio, Arlene O Siefker-Radtke
Published 2021-07-01